Neuroinvest is a high-tech AI investment platform that recreates the behavior of the human brain when it comes to decision making. It forecasts millions of data points on different markets based on ...

The latest announcement is out from Galapagos ( (NL:GLPG) ).

Rigetti’s quantum leap: 335% stock surge, groundbreaking tech, and Q3 forecasts. Read here for an investment analysis of RGTI ...

Artificial empathy (AE) is no longer a curiosity; it's becoming a measurable phenomenon. In this meta-analysis, in 13 of 15 ...

What Is Sunfort Portdex? Sunfort Portdex stands at the forefront of 2025’s trading innovation, emerging as an AI-driven ...

New Delhi has carefully cultivated relationships with both Washington and Moscow, seeking to maintain strategic flexibility ...

Harm reduction treats AI integration as collaborative learning, rather than compliance. Teachers and students can learn ...

The most recent edition of Intergeo – the world’s leading geospatial gathering – left no doubt that geoinformation has moved ...

Cabot Corporation shows weak fundamentals, declining volumes, and bearish technicals with rising risk and tariff uncertainty.

Coya Therapeutics (COYA) caught investors' attention after announcing a follow-on equity offering of its common stock. Equity offerings like this often prompt questions about a company's capital needs ...

The consensus analyst price target for Xylem has edged up to $158.67 from $157.89, signaling a modest increase in positive sentiment among experts. This incremental move comes as several analysts ...

This paper presents the status quo of cryptocurrency-themed malicious extensions and unveils the characteristics that can ...